title: [Positron emission tomography in the diagnosis and monitoring of patients with nonseminomatous germ cell tumours].
abstract: The role of 18-fluorodeoxyglucose positron emission tomography (FDG-PET) in the diagnosis and monitoring of nonseminomatous germ cell tumours is currently unclear. Clinical studies have suggested that FDG-PET has relatively low sensitivity and specificity in the setting of initial staging and viability assessment of post-chemotherapy residual lesions. On the other hand, FDG-PET provides potentially useful information in patients with elevated tumour markers and/or multiple residual lesions with limited resectability. Other possible indications of FDG-PET are the early assessment of tumour chemosensitivity and the diagnosis of inflammatory treatment complications.
authors.affiliation: Onkologické oddelení, Fakultní Thomayerova nemocnice a 1. LF UK, Praha. tomas.buchler@ftn.cz
authors.forename: T
authors.initials: T
authors.lastname: Büchler
authors.forename: K
authors.initials: K
authors.lastname: Simonová
authors.forename: P
authors.initials: P
authors.lastname: Fencl
authors.forename: J
authors.initials: J
authors.lastname: Abrahámová
mesh_terms: D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D009373:Neoplasms, Germ Cell and Embryonal / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000556:secondary; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D012680:Sensitivity and Specificity; D013736:Testicular Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18